Frank H. Laukien is the Chairman, President and Chief Executive Officer of Bruker Corporation (Nasdaq: BRKR).
As of January 2021, he has also been appointed as a Visiting Scholar in the Harvard Origins of Life Initiative and the Harvard University Department of Chemistry & Chemical Biology.
Dr. Laukien served as a director of the Analytical, Life Science and Diagnostic Association (ALDA) for several terms, including as Chairman from 2002 to 2003.
He holds a Bachelor of Science in physics from MIT (1984), as well as a Ph.D. in chemical physics from Harvard University (1988).
He served on the Dean’s Advisory Committee of the School of Science of the Massachusetts Institute of Technology until 2014. He serves on the Visiting Committee for the MIT Department of Chemistry.
In 2017, he was elected a Senator of acatech, the German National Academy of Science and Engineering.
Dr. Laukien was lead organizer of the Cancer & Evolution Symposium, Oct. 14-16, 2020, and he is now the lead organizer of the Cancer & Evolution Symposium Series (CESS) as of December 2020.
A complete list of publications and patents is available upon request. Recent submissions for publications related to cancer research:
‘The Evolution of Evolutionary Processes in Organismal and Cancer Evolution’, F.H. Laukien, submitted to Special Issue in Progress in Biophysics & Molecular Biology, dedicated to Cancer & Evolution Symposium, Oct. 14-16, 2020.
‘NATURAL EVOLUTION 4.0: Feedback-Driven and Actively Accelerated Biological Evolution’, F.H. Laukien, book manuscript submitted to academic publishers, fall of 2020.